As of Feb 22
| +0.57 / +14.47%|
The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +33.04% increase from the last price of 4.51.
The current consensus among 1 polled investment analysts is to Buy stock in Brainstorm Cell Therapuetics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.